Events & Presentations Events & Presentations Upcoming Events There are no upcoming events scheduled at this time. Past Events 3/09/21 at 7:00 AM EST H.C. Wainwright Global Life Sciences 2021 Virtual Conference Listen to webcast 2/24/21 at 1:40 PM EST 10th Annual SVB Leerink Global Healthcare Conference Listen to webcast Presentations Title Date Documents Corporate Presentation May 2021 May 6, 2021 Add Files Corporate Presentation May 2021 2.1 MB European School of Haematology (ESH) 2nd Translational Research E-Conference March 5, 2021 Add Files KER-050, a Novel Inhibitor of TGF-β Superfamily Signaling, Induces Red Blood Cell Production by Promoting Multiple Stages of Erythroid Differentiation 1.1 MB Targeted ALK2 Inhibition as a Therapeutic Approach to Reducing Hepcidin and Elevating Serum Iron 714.1 KB 62nd American Society of Hematology (ASH) Annual Meeting and Exposition December 7, 2020 Add Files KER-050, a Novel Inhibitor of TGF-β Superfamily Signaling, Induces Red Blood Cell Production by Promoting Multiple Stages of Erythroid Differentiation 3.1 MB KER-050, a Modified ActRIIA Ligand Trap, Alleviates Cytopenia Arising from Multiple Etiologies 706 KB Administration of KER-047, a Novel ALK2 Inhibitor, Elicited Robust and Sustained Increases in Serum Iron in Healthy Participants 702.1 KB Selective Inhibition of ALK2 Signaling Suppresses Serum Hepcidin and Increases Serum Iron 797.8 KB ASBMR 2020 Annual Meeting Virtual Event September 11, 2020 Add Files KER-012, a Novel Activin Receptor Type II Ligand Trap Increased Bone in Mice via a Unique Mechanism of Action 1.5 MB 25th European Hematology Association (EHA) Congress (2020) June 12, 2020 Add Files Poster Presentation: Administration of KER-050, a Novel ActRIIA Ligand Trap, to Healthy Participants Elicited Robust and Sustained Increases in Hemoglobin and Platelets 1.3 MB Poster Presentation: Administration of KER-050, a Novel ActRIIA Ligand Trap, to Healthy Participants Elicited Robust and Sustained Increases in Hemoglobin and Platelets (Updated as of April 2021) 1.4 MB Poster Presentation: KER-050, a Novel Modified ActRIIA Ligand Trap, Increases Red Blood Cell Production in Cynomolgus Monkeys 1.3 MB Poster Presentation: KER-050, a Novel Inhibitor of TGF-β Superfamily Signaling, Induces Red Blood Cell Production and is a Potential Candidate for the Treatment of Ineffective Erythropoiesis 1.1 MB Oral Presentation: Selective Inhibition of ALK2 Signaling Ameliorates Disease in a Novel Model of Iron Refractory Iron Deficiency Anemia (IRIDA) 2.5 MB
Events & Presentations Upcoming Events There are no upcoming events scheduled at this time. Past Events 3/09/21 at 7:00 AM EST H.C. Wainwright Global Life Sciences 2021 Virtual Conference Listen to webcast 2/24/21 at 1:40 PM EST 10th Annual SVB Leerink Global Healthcare Conference Listen to webcast Presentations Title Date Documents Corporate Presentation May 2021 May 6, 2021 Add Files Corporate Presentation May 2021 2.1 MB European School of Haematology (ESH) 2nd Translational Research E-Conference March 5, 2021 Add Files KER-050, a Novel Inhibitor of TGF-β Superfamily Signaling, Induces Red Blood Cell Production by Promoting Multiple Stages of Erythroid Differentiation 1.1 MB Targeted ALK2 Inhibition as a Therapeutic Approach to Reducing Hepcidin and Elevating Serum Iron 714.1 KB 62nd American Society of Hematology (ASH) Annual Meeting and Exposition December 7, 2020 Add Files KER-050, a Novel Inhibitor of TGF-β Superfamily Signaling, Induces Red Blood Cell Production by Promoting Multiple Stages of Erythroid Differentiation 3.1 MB KER-050, a Modified ActRIIA Ligand Trap, Alleviates Cytopenia Arising from Multiple Etiologies 706 KB Administration of KER-047, a Novel ALK2 Inhibitor, Elicited Robust and Sustained Increases in Serum Iron in Healthy Participants 702.1 KB Selective Inhibition of ALK2 Signaling Suppresses Serum Hepcidin and Increases Serum Iron 797.8 KB ASBMR 2020 Annual Meeting Virtual Event September 11, 2020 Add Files KER-012, a Novel Activin Receptor Type II Ligand Trap Increased Bone in Mice via a Unique Mechanism of Action 1.5 MB 25th European Hematology Association (EHA) Congress (2020) June 12, 2020 Add Files Poster Presentation: Administration of KER-050, a Novel ActRIIA Ligand Trap, to Healthy Participants Elicited Robust and Sustained Increases in Hemoglobin and Platelets 1.3 MB Poster Presentation: Administration of KER-050, a Novel ActRIIA Ligand Trap, to Healthy Participants Elicited Robust and Sustained Increases in Hemoglobin and Platelets (Updated as of April 2021) 1.4 MB Poster Presentation: KER-050, a Novel Modified ActRIIA Ligand Trap, Increases Red Blood Cell Production in Cynomolgus Monkeys 1.3 MB Poster Presentation: KER-050, a Novel Inhibitor of TGF-β Superfamily Signaling, Induces Red Blood Cell Production and is a Potential Candidate for the Treatment of Ineffective Erythropoiesis 1.1 MB Oral Presentation: Selective Inhibition of ALK2 Signaling Ameliorates Disease in a Novel Model of Iron Refractory Iron Deficiency Anemia (IRIDA) 2.5 MB
3/09/21 at 7:00 AM EST H.C. Wainwright Global Life Sciences 2021 Virtual Conference Listen to webcast
